News Details

NCCN Patient Advocacy Summit Explores Advancements and Accessibility in Precision Medicine for People with Cancer

The National Comprehensive Cancer Network® (NCCN®) is hosting an online #NCCNPolicy Summit on the importance of providing quality, accessible, and equitable cancer care to patients in need of biomarker testing and related treatment.

Click HERE to register or visit


Free, live webinar featuring a diverse group of experts discussing how biomarker testing, when used appropriately, allows the cancer care team to more effectively select treatment or risk reducing interventions for patients, while improving survival outcomes and decreasing adverse effects. However, effective use of and access to biomarker testing is highly dependent on health care coverage; patient and provider education; and patient geographic location and socioeconomic status.           

Topics Include:

  • Federal Policy Landscape to Reduce the Impact of Hereditary Cancer
  • State Policy Landscape to Improve Access to Testing to Guide Treatment
  • Solutions for Access to Appropriate Testing
  • Resources for the Cancer Community

When:              Tuesday, December 7, 2021 | 11:00am – 3:00 pm EST  

Fireside Chat:

  • Congresswoman Debbie Wasserman Schultz (D-FL)
  • Congressman Rodney Davis (R-IL)


  • Hilary Gee Goeckner, MSW, American Cancer Society Cancer Action Network

Introduction:                                                                            Moderator:

Robert W. Carlson, MD                                                            Clifford Goodman, PhD

Chief Executive Officer                                                              Senior Vice President

NCCN                                                                                       The Lewin Group

                                                        Panel Members:

Debora S. Bruno, MD, MS

Case Comprehensive Cancer Center

Crystal S. Denlinger, MD, FACP

National Comprehensive Cancer Network

Wenora Johnson

Patient Advocate

Dan Milner, MD, MSc, MBA

American Society of Clinical Pathology

Bhuvana Sagar, MD, MBA


Kristen Santiago, MS

LUNGevity Foundation

Lisa Schlager

Facing Our Risk of Cancer Empowered (FORCE)

Mary Lou Smith, JD, MBA                   

Research Advocacy Network

James Warburton

Novartis Oncology


Monica Bryant, JD

Quick Guide to Appeals for Employer-Sponsored & Individual Health Insurance

Triage Cancer

Peggy Cottrell, MS, CGC

Genetics for Life Program


Nikki Martin, MA

No One Missed


Cassadie Moravek

Know Your Tumor Program

Pancreatic Cancer Action Network (PanCAN)

Media can contact Rachel Darwin at with any questions. Visit for the full agenda, and join the conversation online with the hashtag #NCCNPolicy.

# # #

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) provide transparent, evidence-based, expert consensus recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit for more information and follow NCCN on Facebook @NCCNorg, Instagram @NCCNorg and Twitter @NCCN.